COVID-19 y hígado: una relación crítica
Keywords:
.
Downloads
Download data is not yet available.
References
[1] Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat. Rev. Immunol. 2020; 20(6): 363-74. https://doi.org/10.1038/s41577-020-0311-8.
[2] Mokhtari T, Hassani F, Ghaffari N, Ebrahimi B, Yarahmadi A, Hassanzadeh G. COVID-19 and multiorgan failure: A narrative review on potential mechanisms. J. Mol. Histol. 2020; 51(6): 613-28. https://doi.org/10.1007/s10735-020-09915-3.
[3] Kubes P, Jenne C. Immune responses in the liver. Annu. Rev. Immunol. 2018; 36: 247-77. https://doi.org/10.1146/annurev-immunol-051116-052415.
[4] Schett G., Sticherling M, Neurath, MF. COVID-19: risk for cytokine targeting in chronic inflammatory diseases? Nat. Rev. Immunol. 2020; 20(5): 271-2. https://doi.org/10.1038/s41577-020-0312-7.
[5] Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol. Hepatol. 2020; 5(5): 428-30. https://doi.org/10.1016/S2468-1253(20)30057-1.
[6] Amin M. COVID-19 and the liver: overview. Eur. J. Gastroenterol. Hepatol. 2020; 33(3): 309-11. https://doi.org/10.1097/MEG.0000000000001808.
[7] Metawea MI, Yousif WI, Moheb I. COVID 19 and liver: An A-Z literature review. Dig. Liver Dis. 2021; 53(2): 146-52. https://doi.org/10.1016/j.dld.2020.09.010.
[8] Schaefer EAK, Arvind A, Bloom PP, Chung RT. Interrelationship between coronavirus infection and liver disease. Clin. Liver Dis. 2020; 15(5): 175-80. https://doi.org/10.1002/cld.967.
[9] Elhence A, Vaishnav M, Biswas S, Chauhan A, Anand A, Shalimar. Coronavirus disease-2019 (COVID-19) and the liver. J. Clin. Transl. Hepatol. 2021; 9(2): 247–55. https://doi.org/10.14218/JCTH.2021.00006.
[10] Jothimani D, Venugopal R, Abedin MF, Kaliamoorthy I, Rela M. COVID-19 and the liver. J.Hepatol. 2020; 73(5): 1231-40. https://doi.org/10.1016/j.jhep.2020.06.006.
[2] Mokhtari T, Hassani F, Ghaffari N, Ebrahimi B, Yarahmadi A, Hassanzadeh G. COVID-19 and multiorgan failure: A narrative review on potential mechanisms. J. Mol. Histol. 2020; 51(6): 613-28. https://doi.org/10.1007/s10735-020-09915-3.
[3] Kubes P, Jenne C. Immune responses in the liver. Annu. Rev. Immunol. 2018; 36: 247-77. https://doi.org/10.1146/annurev-immunol-051116-052415.
[4] Schett G., Sticherling M, Neurath, MF. COVID-19: risk for cytokine targeting in chronic inflammatory diseases? Nat. Rev. Immunol. 2020; 20(5): 271-2. https://doi.org/10.1038/s41577-020-0312-7.
[5] Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol. Hepatol. 2020; 5(5): 428-30. https://doi.org/10.1016/S2468-1253(20)30057-1.
[6] Amin M. COVID-19 and the liver: overview. Eur. J. Gastroenterol. Hepatol. 2020; 33(3): 309-11. https://doi.org/10.1097/MEG.0000000000001808.
[7] Metawea MI, Yousif WI, Moheb I. COVID 19 and liver: An A-Z literature review. Dig. Liver Dis. 2021; 53(2): 146-52. https://doi.org/10.1016/j.dld.2020.09.010.
[8] Schaefer EAK, Arvind A, Bloom PP, Chung RT. Interrelationship between coronavirus infection and liver disease. Clin. Liver Dis. 2020; 15(5): 175-80. https://doi.org/10.1002/cld.967.
[9] Elhence A, Vaishnav M, Biswas S, Chauhan A, Anand A, Shalimar. Coronavirus disease-2019 (COVID-19) and the liver. J. Clin. Transl. Hepatol. 2021; 9(2): 247–55. https://doi.org/10.14218/JCTH.2021.00006.
[10] Jothimani D, Venugopal R, Abedin MF, Kaliamoorthy I, Rela M. COVID-19 and the liver. J.Hepatol. 2020; 73(5): 1231-40. https://doi.org/10.1016/j.jhep.2020.06.006.
Published
2021-07-05
How to Cite
Fernández-Martínez , E. (2021). COVID-19 y hígado: una relación crítica. Mexican Journal of Medical Research ICSA, 9(18), 1-2. https://doi.org/10.29057/mjmr.v9i18.7562
Section
Editorial